Federal Register / Vol. 62, No. 208 / Tuesday, October 28, 1997 / Notices 55819

interpretation of available toxicological

information and epidemiologic

evaluations. This information and these

data are to be used to ascertain the

levels of significant human exposure for

the substance and the associated health

effects. The profiles must also include a

determination of whether adequate

information on the health effects of each

substance is available or in the process

of development. When adequate

information is not available, ATSDR, in

cooperation with the National

Toxicology Program (NTP), is required

to assure the initiation of research to

determine these health effects.

Although key studies for each of the

substances were considered during the

profile development process, this

Federal Register notice seeks to solicit

any additional studies, particularly

unpublished data and ongoing studies,

which will be evaluated for possible

addition to the profiles now or in the

future.

The following draft toxicological

profiles will be made available to the

public on or about October 17, 1997.

DocumentHazardous substance CAS No.

1. .......... CADMIUM ............ 007440–43–9

CADMIUM CARBONATE.000513–78–0

CADMIUM CHLORIDE.010108–64–2

CADMIUM OXIDE 01306–19–0

CADMIUM SULFATE.010124–36–4

CADMIUM SULFIDE.01306–23–6

2. .......... CHLORODIBENZO-P-DIOXIN.039227–53–7

DICHLORODIBENZO-P-DIOXIN.050585–39–2

HEPTACHLORODIBENZO-PDIOXIN.037871–00–4

HEXACHLORODIBENZO-PDIOXIN.034465–46–8

OCTACHLORODIBENZO-PDIOXIN.003268–87–9

PENTACHLORODIBENZO-PDIOXIN.036088–22–9

TRICHLORODIBENZO-P-DIOXIN.039227–58–2

TETRACHLORODIBENZO-PDIOXIN.041903–57–5

1,2,3,4,6,7,8-

HEPTACHLORODIBENZO-PDIOXIN.

035822–46–9

3. .......... CHLOROPHENOLS.000088–06–2

2,3,5,6-

TETRACHLOROPHENOL.

000935–95–5

DocumentHazardous substance CAS No.

2,4,5-

TRICHLOROPHENOL.

000095–95–4

2,4,6-

TRICHLOROPHENOL.

000088–06–2

2-

CHLOROPHENOL.

000120–83–2

4-Chlorophenol ..... 000095–57–8

2,3,4,5-

TETRACHLOROPHENOL.

004901–51–3

2,3,4,6-

TETRACHLOROPHENOL.

000058–90–2

4. .......... DORMALDEHYDE 000050–00–0

5. .......... HEXACHLOROCYCLOHEXANE.000608–73–1

HEXACHLOROCYCLOHEXANE,

ALPHA-.

000319–84–6

HEXACHLOROCYCLOHEXANE,

BETA-.

000319–85–7

HEXACHLOROCYCLOHEXANE,

DELTA-.

000319–86–8

HEXACHLOROCYCLOHEXANE,

GAMMA-.

000058–89–9

6. .......... HEXACHLOROCYCLOPENTADIENE.000077–47–4

7. .......... MANGANESE ....... 007439–96–5

8. .......... HYDROGEN SULFIDE.007783–06–4

All profiles issued as ‘‘Drafts for

Public Comment’’ represent ATSDR’s

best efforts to provide important

toxicological information on priority

hazardous substances. We are seeking

public comments and additional

information which may be used to

supplement these profiles. ATSDR

remains committed to providing a

public comment period for these

documents as a means to best serve

public health and our clients.

Dated: October 22, 1997.

Georgi Jones,

Director, Office of Policy and External Affairs,

Agency for Toxic Substances and Disease

Registry.

[FR Doc. 97–28476 Filed 10–27–97; 8:45 am]

BILLING CODE 4163–70–P

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

Centers for Disease Control and

Prevention

Board of Scientific Counselors,

National Center for Infectious

Diseases: Meeting

In accordance with section 10(a)(2) of

the Federal Advisory Committee Act

(Pub. L. 92–463), the Centers for Disease

Control and Prevention (CDC)

announces the following committee

meeting.

Name: Board of Scientific Counselors,

National Center for Infectious Diseases

(NCID).

Times and Dates: 11 a.m.–5:15 p.m.,

December 4, 1997; 8:30 a.m.–2:30 p.m.,

December 5, 1997.

Place: CDC, Auditorium B, 1600 Clifton

Road, NE, Atlanta, Georgia 30333.

Status: Open to the public, limited only by

the space available.

Purpose: The Board of Scientific

Counselors, NCID, provides advice and

guidance to the Director, CDC, and Director,

Page 2 NCID, in the following areas: program

goals and objectives; strategies; program

organization and resources for infectious

disease prevention and control; and program

priorities.

Matters to be Discussed: Agenda items will

include:

1. NCID Update

2. Overview of CDC Emerging Infections

Plan, 1998–2003

3. Charge to the Workgroups

4. Workgroup Sessions:

CDC Plan:

a. Surveillance and Response

b. Applied Research

c. Prevention and Control

d. Infrastructure Bioterrorism Preparedness

5. Workgroup Reports

6. Facilities Update

7. Scientific Updates (Late breakers)

8. Recommendations

Other agenda items include

announcements/introductions; follow-up on

actions recommended by the Board in May

1997; Page 3 and consideration of future

directions, goals, and recommendations.

Agenda items are subject to change as

priorities dictate.

Written comments are welcome and should

be received by the contact person listed

below prior to the opening of the meeting.

Contact Person for More Information:

Diane S. Holley, Office of the Director, NCID,

CDC, Mailstop C–20, 1600 Clifton Road, NE,

Atlanta, Georgia 30333, telephone 404/639-

0078.

Dated: October 22, 1997.

Julia M. Fuller,

Acting Director, Management Analysis and

Services Office, Centers for Disease Control

and Prevention (CDC).

[FR Doc. 97–28480 Filed 10–27–97; 8:45 am]

BILLING CODE 4163–18–P